Shopping Cart
- Remove All
- Your shopping cart is currently empty
TriacetonaMine (Vincubine) protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 g | $29 | In Stock |
Description | TriacetonaMine (Vincubine) protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK); it also inhibits CaCl2 induced agglomeration of thromocyte. Triacetonamine can improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles. |
In vivo | Triacetonamine(TAA)could improve the constructile function of heart mus-cles of acute anemia and decrease the content of malodialdehyde (MDA) in the heart muscles. TAA protects the activitis of superoxide dismutase(SOD) and creatine phos-phate kinase (CPK). It also inhibits CaCl2 induced agglomeration of thromocyte. |
Alias | Vincubine, tmpone, tempidon, Odoratine, 2,2,6,6-Tetramethyl-4-piperidinone |
Molecular Weight | 155.24 |
Formula | C9H17NO |
Cas No. | 826-36-8 |
Smiles | CC1(C)CC(=O)CC(C)(C)N1 |
Relative Density. | 0.9796 g/cm3 (Estimated) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (354.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.